SI Joint Stabilization in Long Fusion to the Pelvis
SILVIA
Sacroiliac Joint Stabilization in Long Fusion to the Pelvis: Randomized Controlled Trial
1 other identifier
interventional
213
5 countries
31
Brief Summary
The purpose of this study is to compare outcomes of subjects undergoing multilevel lumbar fusion (MLF) surgery with and without the iFuse 3-D implants in the "bedrock" trajectory.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2020
Longer than P75 for not_applicable
31 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2019
CompletedFirst Posted
Study publicly available on registry
August 20, 2019
CompletedStudy Start
First participant enrolled
May 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2025
CompletedFebruary 18, 2025
February 1, 2025
4.6 years
August 8, 2019
February 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Proportion with S2AI screw abnormality on CT scan
Proportion of subjects with any of following: S2AI screw breakage, loosening or pullout OR rod breakage distal to S1 on 2-year CT scan as interpreted by an independent bone radiologist
2 years
Incidence of SI Joint pain
Proportion of subjects without SI joint pain at baseline who develop new onset SI joint pain by 2 years
2 years
Change from baseline in self-reported SI joint pain at 2 years
Change from baseline in self-reported SI joint pain on a 0 (no pain) -10 (worst imaginable pain) visual analog scale
2 years
Secondary Outcomes (15)
Proportion of subjects requiring revision, removal, reoperation or supplemental fixation
2 years
Therapeutic injection or other non-medication based intervention
2 years
Oswestry Disability Index
2 years
EuroQol Group Health Questionnaire
2 years
Scoliosis Research Society 22r Patient Questionnaire
2 years
- +10 more secondary outcomes
Study Arms (2)
Standard care
ACTIVE COMPARATORMultilevel Lumbar Fusion Surgery
Standard Care + iFuse 3-D
EXPERIMENTALMultilevel Lumbar Fusion Surgery with additional placement of iFuse 3-D in a trajectory parallel to the S2AI screws
Interventions
Procedure in which 3 or more spinal segments are fused and concomitant pelvic fixation is performed, additionally iFuse 3-D implants are placed in a trajectory parallel to the S2AI screws.
Procedure in which 3 or more spinal segments are fused and concomitant pelvic fixation is performed.
Eligibility Criteria
You may qualify if:
- Age 21-75 at time of screening
- Patient scheduled for multilevel (\>3 levels) spinal fusion surgery with planned fixation to the pelvis using S2AI screws
- Patient has signed study-specific informed consent form
- Patient has the necessary mental capacity to participate and is physically able to comply with study protocol requirements
You may not qualify if:
- Indication for multilevel spine fusion surgery is any of the following:
- Congenital neuromuscular disease
- Prior pelvic fixation (i.e., patient already has S2AI or iliac bolts in place, current surgery indicated to revise this hardware)
- Grade IV spondylolisthesis
- Prior sacroiliac joint fusion/fixation on either side
- Presence of spinal cord stimulator
- Presence of severe hip pain that could impair functional and quality of life improvement from complex spine surgery
- Surgeon plans to use iliac screw for pelvic fixation
- Any known sacral or iliac pathology
- Any condition or anatomy that makes treatment with the iFuse Implant System infeasible
- Known metabolic bone disease
- Severe osteoporosis
- Known allergy to titanium or titanium alloys
- Use of medications known to have detrimental effects on bone quality and soft-tissue healing
- Neurologic condition that would interfere with postoperative physical therapy
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SI-BONE, Inc.lead
Study Sites (31)
Barrow Neurological Institute
Phoenix, Arizona, 85013, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
Scripps Hospital
La Jolla, California, 92037, United States
University of California, San Diego
La Jolla, California, 92037, United States
Keck School of Medicine of USC
Los Angeles, California, 90033, United States
St Mary's Medical Center
San Francisco, California, 94117, United States
University of Colorado Denver
Aurora, Colorado, 80045, United States
Orlando Health Physician Neurosurgery Group
Orlando, Florida, 32806, United States
Axis Spine Center
Coeur d'Alene, Idaho, 82815, United States
Rush University Medical Center
Chicago, Illinois, 60612, United States
Parkview Regional Medical Center
Fort Wayne, Indiana, 46845, United States
University of Michigan
Ann Arbor, Michigan, 48109, United States
William Beaumont Hospital
Royal Oak, Michigan, 48073, United States
University of Minnesota
Minneapolis, Minnesota, 55454, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
University of Buffalo Neurosurgery
Buffalo, New York, 14203, United States
Hospital for Special Surgery
New York, New York, 10027, United States
OrthoCarolina Research Institute
Charlotte, North Carolina, 28207, United States
Ohio State University
Columbus, Ohio, 43210, United States
Tennessee Orthopaedics Alliance
Nashville, Tennessee, 37209, United States
Austin Spine
Austin, Texas, 78705, United States
North Texas Neurosurgical and Spine Center
Fort Worth, Texas, 76104, United States
Texas Back Institute
Plano, Texas, 75093, United States
UVA Spine Center - Ortho
Charlottesville, Virginia, 22903, United States
University of Virginia - Dept of Neurosurgery
Charlottesville, Virginia, 22908-0212, United States
Ortho Virginia Research Institute
Richmond, Virginia, 23235, United States
Virginia Mason
Seattle, Washington, 98101, United States
Epworth HealthCare
Richmond, Victoria, 3121, Australia
Klinikum Magdeburg
Magdeburg, 39130, Germany
Ospedale Civile di Legnano- ASST Ovest Milanese
Legnano, Milan, 20025, Italy
Royal National Orthopaedic Hospital
Stanmore, HA7 4LP, United Kingdom
Related Publications (1)
Polly DW Jr. The Sacroiliac Joint: A Current State-of-the-Art Review. JBJS Rev. 2024 Feb 5;12(2). doi: 10.2106/JBJS.RVW.23.00151. eCollection 2024 Feb 1.
PMID: 38315777DERIVED
Study Officials
- STUDY DIRECTOR
Daniel Cher, MD
SI-BONE
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2019
First Posted
August 20, 2019
Study Start
May 20, 2020
Primary Completion
December 17, 2024
Study Completion
January 15, 2025
Last Updated
February 18, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- After 2-year data are complete.
- Access Criteria
- Interested researcher may submit analysis plans to Yale Open Data Access program
Plan to share data through Yale Open Data Access. Interested researcher may submit analysis plans to Yale.